Chronic obstructive pulmonary disease (COPD) is a heterogeneous group of lung diseases
limiting the airflow due to narrowing of airways, chronic bronchitis and emphysema that …

Background Liquid biomarkers have shown increasing utility in the clinical management of
airway diseases. Salivary and blood samples are particularly amenable to point-of-care …

Chronic obstructive pulmonary disease (COPD) is a slowly progressive and poorly
reversible airway obstruction disease. It is caused either alone or in combination of …

Simple Summary Considering that COPD is a major cause of death and morbidity, this study
therefore aimed to find circulating biomarkers for COPD that could help with early diagnosis …

Advanced glycation end products (AGEs) are compounds formed via non-enzymatic
reactions between reducing sugars and amino acids or proteins. AGEs can accumulate in …

Introduction Current strategies for the prevention of acute exacerbations in chronic
obstructive pulmonary disease (COPD) are primarily based on clinical measurements but …

Background: Acute exacerbation events, which can develop during the natural course of
chronic obstructive pulmonary disease (COPD) can lead to worsening quality of life …

Eine der relevantesten Erkrankungen nicht nur in Deutschland ist angesichts ihrer
Prävalenz, Inzidenz und Mortalität die chronisch obstruktive Lungenerkrankung (COPD) …

Background: Acute exacerbation of chronic obstructive pulmonary disease (AECOPD)
worsens the respiratory symptoms that are usually triggered by infection with bacteria or …